PhoenixLAB positions itself as a strategic partner for the development of preclinical and translational research projects in the field of Inflammatory Bowel Diseases (IBD) and beyond, thanks to solid scientific know-how and validated, cutting-edge technologies.
Preclinical animal models of IBD
We select and customize models based on the needs of the project, with the goal of producing reliable, reproducible, and clinically relevant results, thereby helping to bridge the gap between preclinical research and therapeutic application.
Preclinical models using tissues from patients with IBD
We integrate ex vivo models and organotypic cultures of human intestinal tissue into our preclinical studies, offering our partners highly customizable, reliable solutions that closely reflect the patient’s reality.
Other preclinical animal models of the digestive system and beyond
In addition to IBD, we develop and use models of other digestive system diseases and skin disorders. We also have models of colorectal and skin cancer available for studying the tumor microenvironment and response to drug treatments.
MULTIOMICS
We integrate MULTIOMIC analyses into our studies, with the goal of generating highly informative data, useful for supporting the discovery of new therapeutic targets, optimizing the drug development process, and predicting treatment response.
Scientifici publications e Medical writing
We believe in open science and data quality. For this reason, we collaborate with academic and industrial institutions to produce solid evidence, intended for publication in high-impact scientific journals, actively contributing to the advancement of translational medicine.